OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient?Friendly Access to Testing for Sexually Transmitted Infections

Stock Information for OraSure Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About OraSure Technologies Inc.

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
OraSure Announces First Quarter 2026 Financial Results
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance
OraSure Announces Fourth Quarter 2025 Financial Results
OraSure to Launch OraQuick(TM) HIV Self-Test in Canada

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.